Medical Technology

@techcrunch.com 2 years ago

Everything is accelerating in the exponential age

@techcrunch.com 2 years ago

How Colossal sold investors on a quest to resurrect a woolly mammoth

@digitaltrends.com 4 years ago

CRISPR-Cas9 gene editing could one day ‘turn off’ HIV virus in the body

@xconomy.com 5 years ago

In Landmark Gene-Editing Study, Sangamo Reports Little Benefit

@xconomy.com 5 years ago

Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More

@xconomy.com 5 years ago

Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial

@xconomy.com 5 years ago

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

@xconomy.com 5 years ago

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M